Lieff Cabraser founding partner Elizabeth J. Cabraser was honored by The American Lawyer with its Lifetime Achievement award last night at the annual American Lawyer Industry Awards ceremony in New York City.
In her acceptance speech, Elizabeth made it clear that she isn’t planning to slow down any time soon. “I will strive daily to live up to this recognition,” she said.
She offered her perspective on exactly what it means to be a lawyer—and why it has been her life’s work.
“The law is a profession, a business, an industry, an avocation, a vocation and a calling,” she said, “but more than anything it is an endless and ever-evolving project to which we are each honored to lend the work of our lifetimes.”
Elizabeth concluded her speech by thanking her fellow co-workers, noting that “Nothing I have managed to accomplish could have been done without my partners and colleagues at Lieff Cabraser, beginning with our founder Bob Lieff, and my partners of many years here [in NYC], and in San Francisco and in Nashville… and continuing to our brightest new associates, the Law Stars and Lifetime Achievers of the future.”
Watch the full video of her acceptance speech on The American Lawyer’s site (subscription).
About Elizabeth Cabraser
Name partner and co-founder of Lieff Cabraser, Elizabeth Cabraser chairs the firm’s personal injury and environmental litigation practice groups. One of the nation’s leading class action litigators and possessing unparalleled expertise in complex civil litigation, she has served as court-appointed lead, co-lead, or class counsel in scores of federal multi-district and state coordinated proceedings. Today, she serves in court-appointed leadership positions in several of the nation’s highest profile civil cases, including a solo leadership role in the VW “Clean Diesel” Emissions case, as well as lead positions in the GM ignition switch defect and Takata defective airbag cases, and the recently-filed Fiat Chrysler Jeep Dodge diesel emissions fraud litigation, Generic Drugs Pricing antitrust litigation, and the National Prescription Opiates litigation.